Maastricht

• Treatments of COVID-19 in primary care in the Netherlands Not authorised
  2022-500678-33-00 6 Patients with COVID-19 in the community, referred by their general pra
• An early access study of ivosidenib in patients with a pretreated locally advanced or metastatic cholangiocarcinoma Not authorised
  2022-501463-40-00 5 Locally Advanced or Metastatic Cholangiocarcinoma
• SAFEST Not authorised
  2022-502059-79-00 6 Ischemic stroke or transient ischemic attack
• 18F-FDG versus 68Ga-FAPI-46 as PET tracer in ER-positive breast cancer - a pilot study Not authorised
  2023-508066-15-00 4 Hormone-positive breast cancer
• Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI … Not authorised
  2024-514693-47-00 11 EGFR mutated locally advanced or metastatic non-small cell lung cancer
• Microdosing for ADHD and emotion regulation Not authorised
  2025-520906-36-00 4 Attention Deficit Hyperactivity Disorder (ADHD)
• Single-arm, multicenter, phase II study of immunotherapy in patients with type B3 thymoma and thymic carcinoma previously treated with chemo … Pending
  2023-508658-24-00 4 type B3 thymoma and thymic carcinoma
• RATE: Reduced anticoagulation targets in extracorporeal life support Pending
  2023-509675-16-01 5 All patients who receive ECMO treatment during the study period in one
• Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study Pending
  2024-510617-15-00 5 Non-metastatic resectable pancreatic cancer
• Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases in patients with a low clinical risk sco … Pending
  2024-512850-10-00 5 Resectable colorectal rectal metastases without extrahepatic disease
• Assess effect and safety of intra-arterial autologous mesoangioblast administration to the upper arm of m.3243A>G mutation carriers Pending
  2024-515129-27-00 7 m.3243A>G mutation causing mitochondrial myopathy
• Comparison of two treatments (intrathecal baclofen pump and selective dorsal rhizotomy) for children with cerebral palsy who cannot walk Pending
  2024-518822-33-01 6 Cerebral Palsy
• DAREON®-Lung-1: A study in people with advanced small cell lung cancer to compare obrixtamig plus atezolizumab, carboplatin, and etoposide t … Pending
  2025-520565-51-00 5 small cell lung cancer
• TMSxDCS: Medicinal improvement of brain stimulation for depression. Pending
  2025-521166-95-00 4 Major Depressive Disorder (MDD)
• Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year Pending
  2025-521590-13-00 5 Moderately to Severely Active Crohn’s Disease
• Phase 3 trial of VMX-C001 vs usual pharmacological care in patients taking a FXa direct oral anticoagulant who require urgent surgery with o … Pending
  2025-521632-12-00 5 Patients on Factor Xa inhibitor treatment needing an urgent interventi
• A single arm phase II study evaluating intracranial efficacy of tarlatamab in patients with asymptomatic active brain metastases from small … Pending
  2025-522162-75-00 4 patients with asymptomatic active brain metastases from small cell lun
• MetAddon: Methadone as co-analgesic for patients with metastatic bone pain: a double-blind randomized controlled trial Pending
  2025-522710-22-00 6 Cancer, bone metastasis, pain
• A research study to see how NNC0487-0111 affects the body’s energy use after a weight loss in adults living with obesity, compared to a low- … Pending
  2025-522744-40-00 3 Obesity
• PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer Pending
  2025-522883-34-00 6 Metastatic cervical cancer
• Efficacy, Safety, and Tolerability of DYNE-101 in Participants with Myotonic Dystrophy Type 1 Pending
  2025-522957-20-00 5 Myotonic Dystrophy Type 1
• Improved baseline staging with 68Ga-FAPI-46 PET in non-small cell lung cancer – a pilot study Pending
  2025-523032-39-00 4 Non-small cell lung cancer
• Boosting osimertinib Blood Brain Barrier penetration in patients with epidermal growth factor receptor mutated non-small cell lung cancer (O … Pending
  2025-523033-26-00 4 Patients with EGFR-mutated metastatic NSCLC, without CNS metastases on
• PREOPANC-6 study: dendritic cell immunotherapy after FOLFIRINOX chemotherapy in patients with resectable pancreatic cancer Pending
  2025-523134-28-00 10 ABC borderline resectable pancreatic cancer

Showing 1–24 of 321 trials